Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging

by Hagen Kulbe, Oliver Klein, Zhiyang Wu, Eliane T. Taube, Wanja Kassuhn, David Horst, Silvia Darb-Esfahani, Paul Jank, Salem Abobaker, Frauke Ringel, Andreas du Bois, Florian Heitz, Jalid Sehouli, Elena I. Braicu
Published 2020-07-01

Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging

by Wanja Kassuhn, Oliver Klein, Silvia Darb-Esfahani, Hedwig Lammert, Sylwia Handzik, Eliane T. Taube, Wolfgang D. Schmitt, Carlotta Keunecke, David Horst, Felix Dreher, Joshy George, David D. Bowtell, Oliver Dorigo, Michael Hummel, Jalid Sehouli, Nils Blüthgen, Hagen Kulbe, Elena I. Braicu
Published 2021-03-01

Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy

by Bruno Valentin Sinn, Karsten E. Weber, Wolfgang Daniel Schmitt, Peter A. Fasching, William Fraser Symmans, Jens-Uwe Blohmer, Thomas Karn, Eliane Tabea Taube, Frederick Klauschen, Frederik Marmé, Christian Schem, Elmar Stickeler, Beyhan Ataseven, Jens Huober, Gunter von Minckwitz, Barbara Seliger, Carsten Denkert, Sibylle Loibl
Published 2019-12-01

MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.

by Paul Jank, Claire Gehlhaar, Lederer Bianca, Fontanella Caterina, Schneeweiss Andreas, Thomas Karn, Frederik Marmé, Hans-Peter Sinn, Marion van Mackelenbergh, Bruno Sinn, Dirk-Michael Zahm, Barbara Ingold-Heppner, Christian Schem, Elmar Stickeler, Peter A Fasching, Valentina Nekljudova, Eliane Tabea Taube, Frank Heppner, Volkmar Müller, Carsten Denkert, Sibylle Loibl
Published 2020-01-01